Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder

Urologia Internationalis

Volumn 86, Issue 4, 2011, Pages 453-460

  Wang, Jue ^a   Wang, Fen Wei ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer specific survival; Signet ring cell carcinoma; Surveillance, epidemiology and end results

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER TUMOR; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SIGNET RING CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TRANSURETHRAL RESECTION;

AGED; CARCINOMA; CARCINOMA, SIGNET RING CELL; CELL DIFFERENTIATION; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 79959684570     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000324263     Document Type: Article

References (38)

1. Saphir O: Signet-ring cell carcinoma of the urinary bladder. Am J Pathol 1955;31:223-2311.
2. Holmang S, Borghede G, Johansson SL: Primary signet-ring cell carcinoma of the bladder: a report on 10 cases. Scand J Urol Nephrol 1997;31:145-148.
3. Jakse G, Schneider H, Jacobi G: Urachal signet-ring cell carcinoma, ararevariant of vesical adenocarcinoma: incidence and pathological criteria. J Urol 1978;120:764-766. (Pubitemid 9091418)
4. Kume H, Kanai Y, Tobisu K, Fujimoto H, Tomita K, Kakizoe T: Signet-ring cell carcinoma of the urinary bladder associated with transitional cell carcinoma of the right ureter. Scand J Urol Nephrol 2000;34:278-279. (Pubitemid 32061337)
5. Shinagawa T, Tadokoro M, Abe M, Koshitaka Y, Kouno S, Hoshino T: Papillary urothelial carcinoma of the urinary bladder demonstrating prominent signet-ring cells in a smear. Acta Cytol 1998;42:407-412. (Pubitemid 28193670)
6. Fernandez-Arjona M, Herrero L, Romero JC, Nieto S, Martin R, Pereira I: Synchronous signet-ring cell carcinoma and squamous cell carcinoma arising in an augmented ileo-cystoplasty. Eur Urol 1996;29:125-128. (Pubitemid 26009307)
7. DeMay RM, Grathwohl MA: Signet-ring-cell (colloid) carcinoma of the urinary bladder: cytologic, histologic and ultrastructural findings in one case. Acta Cytol 1985;29:132-136. (Pubitemid 15083855)
8. Kondo A, Ogisu B, Mitsuya H: Signet-ring cell carcinoma involving the urinary bladder: report of a case and review of 21 cases. Urol Int 1981;36:373-379. (Pubitemid 12183786)
9. Kim SS, Choi YD, Nam JH, Kwon DD, Juhng SW, Choi C: Cytologic features of primary signet-ring cell carcinoma of the bladder: a case report. Acta Cytol 2009;53:309-312.
10. Del Sordo R, Bellezza G, Colella R, Mameli MG, Sidoni A, Cavaliere A: Primary signetring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases. Appl Immunohistochem Mol Morphol 2009;17:18-22.
11. Ohtsuki Y, Fukumoto T, Okada Y, Teratani Y, Hayashi Y, Lee GH, Furihata M: Immunohistochemical and ultrastructural characterization of the signet-ring cell carcinoma component in a case of urothelial carcinoma of the urinary bladder. Med Mol Morphol 2010;43:96-101.
12. Lane Z, Hansel DE, Epstein JI: Immunohis-tochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Am J Surg Pathol 2008;32:1322-1326.
13. Ponz M, Luzuriaga J, Robles JE, Guillén F, Urmeneta JM, Salvá A, Zudaire JJ, Berián JM: Primary signet-ring cell carcinoma of the urinary bladder (linitis plastica). Eur Urol 1985;11:212-214. (Pubitemid 15236378)
14. Choi H, Lamb S, Pintar K, Jacobs SC: Primary signet-ring cell carcinoma of the urinary bladder. Cancer 1984;53:1985-1990. (Pubitemid 14127659)
15. Kunze E, Francksen B: Histogenesis of non-urothelial carcinomas of the urinary bladder from pre-existent transitional cell carcinomas: a histopathological and immunohistochemical study. Urol Res 2002;30:66-78. (Pubitemid 36055946)
16. Kunze E, Francksen B, Schulz H: Expression of MUC5AC apomucin in transitional cell carcinomas of the urinary bladder and its possible role in the development of mucussecreting adenocarcinomas. Virchows Arch 2001;439:609-615. (Pubitemid 33071197)
17. Kunze E: Histogenesis of nonurothelial carcinomas in the human and rat urinary bladder. Exp Toxicol Pat hol 1998;50:341-355. (Pubitemid 28439482)
18. Grignon DJ, Ro JY, Ayala AG, Johnson DE: Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 1991;95:13-20.
19. Surveillance, Epidemiology, and End Results (SEER) Program: Public-Use Data (1973-20041), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at: http://www.seer.cancer.gov/ about/expansion.html.
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-4811.
21. Cox DR: Regression models and life-tables. J Royal Stat Soc [B] 1972;34:187-220.
22. Poore TE, Egbert B, Jahnke R, Kraft JK: Signet-ring cell adenocarcinoma of the bladder: linitis plastica variant. Arch Pathol Lab Med 1981;105:203-204. (Pubitemid 11152297)
23. Akamatsu S, Takahashi A, Ito M, Ogura K: Primary signet-ring cell carcinoma of the urinary bladder. Urology 2010;75:615 - 618.
24. Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE: Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol 2009;40:108-116.
25. Romics I, Székely E, Szendroi A: Signet-ring cell carcinoma arising from the urinary bladder. Can J Urol 2008;15:4266-4268.
26. Burnett AL, Epstein JI, Marshall FF: Adenocarcinoma of urinary bladder: classification and management. Urology 1991;37:315-321.
27. Lotan Y, Cadeddu JA, Roehrborn CG, Stage KH: The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urology. J Urol 2004;172:1958-1962. (Pubitemid 39363101)
28. Gore JL, Yu HY, Setodji C, Hanley JM, Litwin MS, Saigal CS: Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer 2010;116:331-339.
29. Gore JL, Litwin MS, Lai J, Yano EM, Madison R, Setodji C, Adams JL, Saigal CS: Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 2010;102:802-811.
30. Hirano Y, Suzuki K, Fujita K, Furuse H, Fukuta K, Kitagawa M, Aso Y: Primary signet-ring cell carcinoma of the urinary bladder successfully treated with intra-arterial chemotherapy alone. Urology 2002;59:601xiii-xvi.
31. Yamamoto S, Ito T, Akiyama A, Miki M, Tachibana M, Takase M, Matsumoto T, Mochizuki M: Primary signet-ring cell carcinoma of the urinary bladder inducing renal failure. Int J Urol 2001;8:190-193. (Pubitemid 34225075)
32. von der Maase H, Hansen SW, Roberts JT, Dogliotti L Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Rovira S, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF: Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000;18:3068-3077.
33. Heidemann J, Gockel HR, Winde G, Herbst H, Domschke W, Lugering N: Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy. Z Gastroenterol 2002;40:33-36. (Pubitemid 34121686)
34. Mizoshita T, Kataoka H, Kubota E, Okamoto Y, Shimura T, Mori Y, Wada T, Ogasawara N, Sasaki M, Kamiya T, Joh T: Gastric pheno-type signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-f luorouracil. Int J Clin Oncol 2008;13:373 - 376.
35. Logothetis CJ, Samuels ML, Ogden S: Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxoru-bicin, and mitomycin-C. Urology 1985;26:252-255. (Pubitemid 17045603)
36. Ohnita T, Sakai H, Matsuo M, Hisamatsu H, Shimokawa I, Saito Y: Primary signet-ring cell adenocarcinoma of the bladder with elevated serum carbohydrate antigens 19-9 and 50. J Urol 1998;159:1641. (Pubitemid 29117360)
37. Braun EV, Ali M, Fayemi AO, Beaugard E: Primary signet-ring cell carcinoma of the urinary bladder: review of the literature and report of a case. Cancer 1981;47:1430-1435. (Pubitemid 11090513)
38. Gore JL, Kwan L, Saigal CS, Litwin MS: Marriage and mortality in bladder carcinoma. Cancer 2005;104:1188-1194. (Pubitemid 41278953)